chemotherapeutic drugs

Related by string. chemotherapeutic drug * chemotherapeutics . Chemotherapeutic : radioactive isotopes chemotherapeutics . chemotherapeutic agents carboplatin . RH1 targeted chemotherapeutic agent . conventional chemotherapeutic agents / Drugs . DRUG . Drug . DRUGS : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration . Drug Administration FDA * *

Related by context. All words. (Click for frequent words.) 76 chemotherapeutic agents 73 chemotherapeutics 71 chemotherapies 70 chemotherapeutic 70 anticancer drugs 69 anticancer agents 68 proteasome inhibitors 68 cytotoxic agents 68 chemotherapeutic drug 67 Cisplatin 67 cytotoxic 67 taxol 67 anticancer therapies 67 EGFR inhibitors 66 hormonal therapies 66 anti angiogenic drugs 66 anticancer therapy 65 molecularly targeted 65 doxorubicin 65 TNFa 65 PARP inhibitors 65 HDAC inhibitors 65 alkylating agent 65 imatinib Gleevec 65 chemotherapeutic agent 65 immune modulating 64 tyrosine kinase inhibitors 64 bleomycin 64 taxanes 64 Doxorubicin 64 etoposide 64 MEK inhibitors 64 alkylating agents 64 antiangiogenic 64 MMP inhibitors 64 immunotoxins 64 enzyme inhibitors 64 cisplatin 64 Mitoxantrone 64 SERMs 64 idarubicin 63 tyrosine kinase inhibitor 63 erlotinib Tarceva 63 selective inhibition 63 nucleoside analogs 63 vinca alkaloids 63 kinase inhibitors 63 chemotherapeutic regimens 63 peptide antigens 63 Gefitinib 63 histone deacetylase inhibitors 63 flavopiridol 63 anticancer agent 63 novel peptide 63 anti angiogenic agents 62 antitumor 62 paclitaxel Taxol 62 chemotherapy regimens 62 pegfilgrastim 62 endoxifen 62 trastuzumab Herceptin 62 erlotinib Tarceva ® 62 immunosuppressive therapies 62 conventional chemotherapies 62 CLL cells 62 retinoic acid 62 mTOR inhibitors 62 tubulin binding 62 vorinostat 62 glucocorticoids 62 multitargeted 62 DFMO 62 chemopreventive agents 62 immune suppressing 62 gamma secretase inhibitors 62 UsiRNAs 62 standard chemotherapy regimens 62 VEGF inhibitors 62 myeloma cells 62 deacetylase inhibitors 61 TKIs 61 HGS# 61 mycophenolate mofetil 61 topotecan 61 p# inhibitors 61 immune modulator 61 L dopa 61 lapatinib Tykerb 61 CDDO Im 61 EGF receptor 61 fulvestrant 61 Smac mimetic 61 tumor cells 61 enzastaurin 61 docetaxel Taxotere 61 Protease inhibitors 61 BRAF inhibitors 61 vincristine 61 neurotrophic factors 61 microtubule inhibitor 61 direct thrombin inhibitors 61 cisplatin chemotherapy 61 neuro protective 61 IAP inhibitors 61 anti tubercular 61 MEK ERK 61 forskolin 61 VEGF receptor 61 nucleoside analogues 61 uric acid lowering 61 cardiotoxic 61 beta adrenergic 61 vinblastine 61 pimozide 61 gefitinib Iressa 61 immunomodulator 61 hedgehog pathway 61 HSP# inhibitor 61 immunosuppressive agents 60 cytotoxic chemotherapy 60 Preclinical studies suggest 60 immunosuppressive regimens 60 gamma secretase inhibitor 60 EGFR tyrosine kinase inhibitors 60 glioma cells 60 selective inhibitors 60 apoptotic pathway 60 bortezomib Velcade 60 bevacizumab Avastin ® 60 neurotrophins 60 endostatin 60 tumor antigens 60 echinocandins 60 calcineurin 60 #ME# 60 enzyme inhibitor 60 protein kinase inhibitor 60 inhibitory effects 60 therapies 60 xenograft models 60 trastuzumab Herceptin ® 60 histone deacetylase inhibitor 60 Cremophor 60 cytotoxic therapies 60 photosensitiser 60 chemotherapeutic treatments 60 androgen receptors 60 HuLuc# 60 gemcitabine Gemzar 60 MGd 60 interferons 60 NNRTIs 60 leflunomide 60 Smac mimetics 60 docetaxel Taxotere R 60 bevacizumab Avastin 60 cilengitide 60 intravenous bisphosphonates 60 OMP #M# 60 immunomodulatory 60 act synergistically 60 histone deacetylases 60 anticancer treatments 60 chemopreventive agent 60 humanized antibody 60 histone deacetylase HDAC inhibitors 60 anti angiogenic agent 60 docetaxel chemotherapy 60 angiogenesis inhibitor 60 cyclosporin 60 signaling cascades 60 rapamycin 60 protease inhibitors 60 cytoprotective 60 cediranib 59 HDAC inhibition 59 anticancer 59 immunosuppressant drug 59 pertuzumab 59 inhibit replication 59 oral antiviral 59 LY# [003] 59 PKC# 59 vitamin D analogs 59 Amplimexon 59 inhibiting tumor 59 antiangiogenic agents 59 sorafenib Nexavar 59 Th2 cytokines 59 antiangiogenic therapy 59 CA4P 59 dasatinib Sprycel 59 azoles 59 immunosuppressive drugs 59 lipid lowering therapies 59 iRGD 59 imetelstat 59 TNF inhibitors 59 EGFR pathway 59 lenalidomide dexamethasone 59 gemcitabine 59 LHRH agonists 59 Trastuzumab 59 HbF 59 5 FU 59 cytostatic 59 humanized monoclonal antibodies 59 therapeutic regimens 59 small molecule inhibitors 59 CTLA4 Ig 59 EGFr 59 interferon IFN 59 azacytidine 59 photosensitizer 59 antitumor effects 59 bortezomib 59 anthracyclines 59 tyrosine kinase inhibitors TKIs 59 chemotherapy 59 immune modulatory 59 NF kappaB activation 59 CTLA 4 59 nucleosides 59 cytotoxics 59 biologic therapies 59 cisplatin resistant 59 vasodilators 59 superficial bladder cancer 59 Bortezomib 59 JAK inhibitors 59 triterpenoids 59 busulfan 59 antisense compounds 59 retinoids 59 biodegradable nanoparticles 59 small interfering RNA 59 immunosuppressive 59 AEG# 59 transdermally 59 gastrin 59 anti proliferative 59 tumor hypoxia 59 Erlotinib 59 leucovorin 59 rituximab Rituxan 59 IFN alpha 59 ligands 59 siRNA molecules 59 rHuPH# 59 pyridostigmine 59 antiviral therapies 59 PGE2 59 antidiabetic drugs 59 hydralazine 59 prostaglandin synthesis 59 ixabepilone 59 Symadex 59 TRV# [001] 59 proteasome inhibitor bortezomib 59 potent cytotoxic 59 Epothilones 59 drug zotarolimus 59 ganciclovir 59 sulindac 59 gefitinib 59 HCV protease 59 anti androgen 59 EphA2 59 IGFBP 3 59 GAP #B# 59 immune stimulatory 59 amikacin 58 GRN#L 58 HER2 receptors 58 Vandetanib 58 denileukin diftitox 58 ENMD # 58 aminoglycosides 58 Platinol ® cisplatin 58 glioblastoma cells 58 antimetabolite 58 interleukins 58 Zoledronic acid 58 endogenous ligands 58 liposomes 58 PKM2 58 LNP formulations 58 GSK3 58 PXD# 58 molecular biomarkers 58 antiandrogen 58 taxane chemotherapy 58 NF kB pathway 58 radiofrequency ablation RFA 58 immunomodulatory effects 58 docetaxel Taxotere ® 58 albumin bound paclitaxel 58 Aromatase inhibitors 58 immuno modulatory 58 nanocarrier 58 AMPK activators 58 Cytoxan 58 Azedra 58 nifurtimox 58 REOLYSIN ® 58 decitabine 58 EP1 receptor 58 prostanoid 58 administered systemically 58 pharmacokinetic interactions 58 Gleevec resistant 58 BRAF kinase 58 VAPRISOL 58 BChE 58 molecularly targeted therapies 58 polyamines 58 oral prodrug 58 immunomodulatory properties 58 pDCs 58 integrin receptors 58 antiangiogenic drugs 58 CCR2 58 mAbs 58 inhibit viral replication 58 vaginal microbicides 58 monoclonal antibody therapies 58 Vidofludimus 58 proteasome inhibitor 58 HGS ETR1 mapatumumab 58 gabapentin Neurontin 58 anti resorptive 58 LHRH 58 taxane therapy 58 Camptothecin 58 RNAi compounds 58 Valproic acid 58 glucocorticoid 58 DMARDS 58 rifamycins 58 mapatumumab 58 paclitaxel cisplatin 58 dexamethasone Decadron 58 COX inhibitors 58 interferon 58 ISTODAX 58 systemic antifungal 58 bacterial enzyme 58 siRNA binds 58 endocrine therapies 58 5 Fluorouracil 58 Gleevec imatinib 58 immunotoxin 58 antineoplastic 58 Panzem R NCD 58 camptothecin 58 somatostatin receptors 58 adenoviral 58 Anthracycline 58 PHY# [002] 58 phosphate S1P 58 Pemetrexed 58 hematopoietic cells 58 sulfasalazine 58 treating neuropathic pain 58 nicotinic acid 58 adeno associated viruses 58 HCV protease inhibitors 58 curcumin 58 arsenic trioxide 58 suppressor cells 58 chemoresistance 58 EGFR antibodies 58 Pertuzumab 58 EGFR TKIs 58 MDSCs 58 procaspase 3 58 HMG CoA reductase inhibitors 58 retinoid 58 antidiabetic 58 liposomal doxorubicin 58 immunosuppressant 58 #HT#A 58 CBLC# 58 panitumumab Vectibix 58 DACH platinum 58 predictive biomarkers 58 synthetic retinoid 58 immune suppressive 58 selegiline 58 BCR ABL 58 Bisphosphonates 58 Taxanes 58 GnRH agonists 58 liposomal formulation 58 Celecoxib 58 BRAF inhibitor 58 trans retinoic acid ATRA 58 Imatinib 58 resolvins 58 VEGF pathway 58 insulin sensitizing 58 immune suppression 58 bryostatin 58 gemcitabine chemotherapy 58 PEGPH# 58 CD# expressing 58 Interferon alpha 58 immunomodulators 58 OHR/AVR# 58 KIT mutations 58 olaparib 58 Fludara 58 anionic backbone 58 Squalamine 58 FK# 58 hydroxychloroquine 58 antisense inhibitors 58 vinca alkaloid 58 vincristine sulfate 58 TKI therapy 58 CYP #A# 58 IGF 1R 58 epithelial tumors 58 alpha interferon 58 antisense oligonucleotides 58 elastase 58 immune modulators 58 thalidomide Thalomid 58 Anticholinergic 58 intravesical instillation 57 mitochondrial toxicity 57 ALK inhibitor 57 sd rxRNA 57 Glucocorticoids 57 Seliciclib 57 Fibroblast Growth Factor Receptor 57 DNA gyrase 57 anti angiogenic 57 antimetabolites 57 Vincristine 57 anthracycline chemotherapy 57 ACAT2 57 panobinostat 57 Taxol ® 57 corticosteroid dexamethasone 57 PPARγ 57 topical formulations 57 multikinase inhibitor 57 neurotrophic 57 immunotherapies 57 DMARDs 57 BRAF mutation 57 antitumor effect 57 radiolabeled antibodies 57 polyketides 57 NKT cells 57 Monoclonal antibodies 57 orally dosed 57 antitumour 57 Nanobodies ® 57 mecamylamine 57 siRNA therapeutics 57 opiod 57 STAT3 57 Nonsteroidal anti inflammatory 57 imatinib therapy 57 dexrazoxane 57 ceramide 57 Aurora kinase 57 diseased cells 57 bexarotene 57 trans retinoic acid 57 preclinically 57 orally bioavailable 57 adriamycin 57 rituximab 57 HDAC6 57 interferon alfa 57 Irinotecan 57 JAK2 inhibitors 57 Imprime PGG 57 lenalidomide Revlimid R 57 AMN# [001] 57 nanocarriers 57 radiation chemoradiation 57 IGF IR 57 CYT# potent vascular disrupting 57 PARP inhibitor 57 metastatic melanomas 57 calcitriol 57 cellular pathways 57 NF kB activation 57 preclinical xenograft models 57 iron chelators 57 topical retinoids 57 WT1 57 acetylcholinesterase AChE 57 trabectedin 57 peptide inhibitors 57 GPIIb IIIa 57 alkylating 57 VEGFb 57 HIV protease inhibitors 57 Taxotere docetaxel 57 microtubule targeting 57 pyrazinamide 57 calcineurin inhibitors 57 cytotoxic effects 57 CYP#A# inhibitors 57 antifolate 57 Src inhibitors 57 L asparaginase 57 itraconazole 57 paclitaxel Taxol ® 57 tenofovir Viread 57 induce apoptosis 57 cancer immunotherapies 57 Hedgehog pathway 57 herceptin 57 anticoagulant heparin 57 Tumor Necrosis Factor 57 visilizumab 57 Skp2 57 anti mitotic 57 Neulasta ® 57 biodistribution 57 enveloped viruses 57 effector cells 57 Lisofylline 57 cyclophosphamide 57 PI3K inhibitors 57 CCL# 57 alefacept 57 mesothelin 57 5FU 57 epirubicin 57 hyperthermia therapy 57 inducing apoptosis 57 leukemic stem cells 57 inhaled anesthetics 57 AT1R 57 potent inhibitors 57 amphotericin B 57 cetuximab Erbitux R 57 tumor microenvironment 57 Aliskiren 57 PROCHYMAL 57 beta2 adrenergic receptor 57 Bevacizumab 57 solid tumors 57 fibrinolytic 57 MyVax R 57 mutational status 57 mGluR5 antagonist 57 CXCR4 receptor 57 Hsp# inhibitors 57 B7 H3 57 PI3K Akt 57 insulin sensitizers 57 anti CD3 57 Vidaza ® 57 Etoposide 57 antifungal agents 57 imatinib 57 chemopreventive 57 ErbB2 57 Dasatinib 57 PARP inhibition 57 antitumoral 57 IAP inhibitor 57 Sorafenib 57 macrolide antibiotics 57 pro apoptotic 57 chemotherapy docetaxel 57 aminoglycoside 57 chemo resistant 57 photodynamic therapy 57 antisense drugs 57 proton pump 57 FUSILEV enhances 57 PI3K inhibitor 57 cytotoxicity 57 azole 57 receptor tyrosine kinase inhibitor 57 DsiRNA 57 SOD1 57 antihormonal 57 standard chemotherapy regimen 57 FLT3 57 depsipeptide 57 steroid prednisone 57 radiolabeled TM# 57 bicalutamide 57 pentamidine 57 isoproterenol 57 targeting PCSK9 57 effector functions 57 sirolimus 57 HDACs 57 antiepileptics 57 proteins peptides 57 nanomedicines 57 corticosteroid therapy 57 polymerase inhibitors 57 adipiplon 57 anti VEGF 57 PLX# 57 Hycamtin 57 cetuximab Erbitux 57 activate p# 57 oxysterols 57 Xanafide 57 nucleotide analogs 57 breast cancer metastasis 57 bioactive molecules 57 oncoproteins 57 p# activation 57 milatuzumab 57 Herceptin trastuzumab 57 Sutent sunitinib 57 cytarabine 57 pan HDAC inhibitor 57 Bleomycin 57 Immunosuppressive drugs 57 seliciclib 57 Paraplatin ® 57 IgG1 antibody 57 allopurinol 57 transgene expression 57 protein kinase C 57 GRK2 56 metaglidasen 56 SARMs 56 oncoprotein 56 chemotherapeutic regimen 56 lipid particles 56 fusion proteins 56 EGCG 56 micro RNAs 56 effector function 56 Tarceva erlotinib 56 antiproliferative effects 56 potent anticancer 56 nucleoside analog 56 amifostine 56 lentiviral vectors 56 GBM tumors 56 paclitaxel 56 Azathioprine 56 cetuximab 56 Cytarabine 56 neuroprotectant 56 oncolytic 56 Xeloda capecitabine 56 HDACi 56 Doxil 56 valproic acid 56 antiinflammatory 56 phenoxodiol 56 Vidaza azacitidine 56 antimitotic 56 lipid nanoparticles 56 CD8 T cells 56 vaccine adjuvant 56 temozolomide 56 Locked Nucleic Acid LNA 56 enzyme cytochrome 56 Vorinostat 56 cyclophosphamide Cytoxan 56 parthenolide 56 adenosine A2A receptor 56 scorpion toxin 56 vascular disrupting agents 56 liposomal formulations 56 Raltegravir 56 TNF α 56 renoprotective 56 UDCA 56 systemic toxicity 56 HGS ETR2 56 Tyrima 56 peroxynitrite 56 SERCA2a 56 sd rxRNA compounds 56 AKT inhibitor 56 antimetastatic 56 XmAb# 56 glutamate receptors 56 fumagillin 56 synthetic peptides 56 SGLT2 inhibitors 56 HGS ETR1 56 ascorbate 56 toxic misfolded proteins 56 Pegylated Interferon 56 Gemcitabine 56 PPARgamma 56 pro angiogenic 56 Corticosteroids 56 Gemzar gemcitabine 56 ursodeoxycholic acid 56 TGF β 56 cisplatin carboplatin 56 Herbal medicines 56 menadione 56 erythropoietic 56 iNOS 56 nanomolar 56 Neuradiab 56 IFNs 56 matrix metalloproteinases 56 antitumor immune 56 VEGFR2 56 Th2 cells 56 naturally occurring tannins 56 immunomodulatory therapy 56 Calcitonin 56 Akt activation 56 antiemetics 56 taxane 56 JAK3 56 EGFR protein 56 Zolinza 56 alpha interferons 56 bacterial toxins 56 eflornithine 56 TLR8 agonist 56 kinase inhibitor 56 ubiquinone 56 miRNA molecules 56 d4T stavudine Zerit 56 OXi# 56 Taxol paclitaxel 56 SIRT2 56 Foradil Aerolizer 56 Ontak 56 therapeutic monoclonal antibody 56 adrenergic receptors 56 inflammatory cytokines 56 pegylated liposomal doxorubicin 56 serotonin receptor 56 Onconase 56 N Myc 56 nutlin 3a 56 prednisone prednisolone 56 EGFR 56 receptor antagonists 56 cardiac toxicity 56 virus AAV 56 incretin 56 tegafur 56 prostaglandin E2 56 antiandrogens 56 cytotoxins 56 Cyclosporine 56 racemic mixture 56 NKG2D 56 relapsed ovarian cancer 56 imexon 56 luteolin 56 IFN beta 56 antiplatelet therapies 56 sorafenib 56 TGF alpha 56 anticancer activity 56 antitumor efficacy 56 specific lectin receptors 56 CYP3A 56 adrenal suppression 56 beta lactam antibiotics 56 endoplasmic reticulum stress 56 Chemophase 56 TNF inhibitor 56 antiviral compounds 56 TLR agonists 56 conventional DMARDs 56 Orally administered 56 gonadotropins 56 microvascular endothelial cells 56 sulforaphane 56 oncolytic virus 56 demethylating agents 56 5 fluorouracil 56 letrozole Femara 56 luteinizing hormone releasing 56 synovial cells 56 heparanase 56 metastatic colorectal 56 TLR8 56 Homspera 56 Angiolix 56 acid suppressing 56 cardiac glycosides 56 irinotecan chemotherapy 56 androgen receptor AR 56 immunosuppressives 56 neuroinflammatory 56 infliximab Remicade 56 rifamycin 56 beta agonists 56 GM CSF 56 tumorigenic 56 NRTIs 56 TACE 56 nanoparticles 56 myopathy rhabdomyolysis 56 Tarvacin 56 systemically administered 56 beta adrenergic receptors 56 Doxil ® 56 beta interferons 56 Everolimus 56 cidofovir 56 Velcade bortezomib 56 Stat5 56 PTP 1B 56 mutated KRAS gene 56 KL4 surfactant 56 tenascin C 56 EGFR inhibitor 56 DiLA2 56 neratinib 56 cyclin E 56 immunomodulating 56 EGFR inhibition 56 heparins 56 Sunitinib 56 microwave hyperthermia 56 CD# antibody [001] 56 colony stimulating factors 56 YONDELIS 56 membrane receptors 56 glycolipids 56 ADI PEG 56 biologic therapeutics 56 Sertoli cells 56 nonsteroidal 56 Cyclosert 56 Clofarabine 56 targeting CD# 56 antiestrogen 56 Epidermal Growth Factor Receptor 56 spironolactone 56 monoamine oxidase inhibitors 56 liposome encapsulated 56 PDGF receptor 56 pRb 56 radioprotective 56 IL #p# 56 BCR ABL protein 56 naturally occurring compounds 56 overlapping toxicities 56 monoclonal antibodies mAbs 56 TLR9 56 marketed EGFR 56 PDGFR 56 mesothelial cells 56 apoptosis programmed cell 56 cephalosporin antibiotics 56 Novartis Gleevec 56 bile acid 56 DNA intercalator 56 inhibits protein synthesis 55 dose cytarabine 55 Copegus ribavirin 55 blood clot dissolving 55 anti leukemic 55 angiogenesis inhibitors 55 EpCAM 55 HCV replication 55 Erbitux cetuximab 55 cell signaling pathway 55 Fludarabine 55 RNA antagonist 55 TNF antagonist 55 Scorpion venom 55 HER3 55 EGFRIs 55 talabostat 55 proliferative disorders 55 antibody fragment 55 PI3K AKT 55 Anticalins ® 55 Gliadel Wafer 55 tumor vasculature 55 TTR gene 55 mutant proteins 55 COX enzymes 55 TLR9 agonists 55 IDO inhibitor 55 Crizotinib 55 indinavir 55 TRIM5a 55 tumor antigen 55 phototoxicity 55 miR #a [002] 55 factor TNF 55 interferon alpha 55 intranasal corticosteroids 55 muscarinic 55 small molecule tyrosine 55 Novartis AG Gleevec 55 collagenase 55 cannabinoid receptors 55 TNF alpha inhibitors 55 anti angiogenic therapies 55 PECAM 1 55 dihydrofolate reductase 55 basiliximab 55 Phylomer ® 55 androgens 55 DHFR 55 factor Xa inhibitor 55 BMS # 55 CORT # 55 dasatinib 55 inhibit tumor 55 investigational therapies 55 siRNAs 55 anti fibrotic 55 angiogenesis inhibition 55 myo inositol 55 anti CD3 antibody 55 ERK signaling 55 potentiator 55 antiangiogenesis 55 antagomirs 55 mutant huntingtin 55 glitazones 55 antibiotic minocycline 55 Exosomes 55 pegylated interferons 55 selectively inhibited 55 patients undergoing chemotherapy 55 echinocandin 55 somatostatin analogs 55 Radiofrequency ablation 55 biomarker identification 55 beta lactam antibiotic 55 fibrate drugs 55 rBChE 55 cognitive enhancer 55 siRNA 55 telomerase inhibitor 55 TAp# 55 Oxaliplatin 55 abzymes 55 Sym# 55 intracellular pathways 55 CD#L 55 antiresorptive 55 alpha synuclein 55 induced neurotoxicity 55 Fulvestrant 55 #I TM# 55 EGFR HER2 55 ESBA# 55 TRAIL receptor antibodies 55 non nucleoside 55 synthetic analogues 55 sd rxRNAs 55 topoisomerase II 55 Apo2L 55 methotrexate 55 neoadjuvant chemotherapy 55 HER2 positive metastatic breast 55 Losartan 55 kidney urologic 55 pro inflammatory cytokines 55 Carfilzomib 55 antifolates 55 liposome 55 liposomal 55 antidepressants SSRIs 55 neurofibromin 55 PSMA ADC 55 immune suppressants 55 SOCS1 55 aldose reductase inhibitors 55 thymidylate synthase 55 Vectibix monotherapy 55 Cetuximab 55 Lenocta 55 Notch inhibitor 55 OncoVEX GM CSF 55 CD# antibodies 55 immunological diseases 55 Liposomal 55 ischemic tissues 55 tumor subtypes 55 adoptive immunotherapy 55 B7 H1 55 diseased tissues 55 endosomal release 55 protease inhibitors PIs 55 inhibitor RG# 55 anticlotting 55 gemcitabine cisplatin 55 PHD2

Back to home page